Molecular Data Inc
NASDAQ:MKD
Molecular Data Inc
Cash from Financing Activities
Molecular Data Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Molecular Data Inc
NASDAQ:MKD
|
Cash from Financing Activities
¥529.1m
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Cash from Financing Activities
-¥63.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
Pinduoduo Inc
NASDAQ:PDD
|
Cash from Financing Activities
-¥9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
JD Health International Inc
HKEX:6618
|
Cash from Financing Activities
-¥925.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-94%
|
CAGR 10-Years
N/A
|
|
Meituan
HKEX:3690
|
Cash from Financing Activities
-¥2.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
JD.Com Inc
HKEX:9618
|
Cash from Financing Activities
-¥5.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Molecular Data Inc's Cash from Financing Activities?
Cash from Financing Activities
529.1m
CNY
Based on the financial report for Dec 31, 2020, Molecular Data Inc's Cash from Financing Activities amounts to 529.1m CNY.
What is Molecular Data Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
26%
Over the last year, the Cash from Financing Activities growth was 254%. The average annual Cash from Financing Activities growth rates for Molecular Data Inc have been 26% over the past three years .